The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Name: The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
License: Public Domain

Glaxo Wellcome

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

acquired-immunodeficiency-syndrome hiv-infections na

lymphatic disease, hiv infections, acquired immunodeficiency syndrome, zidovudine, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Related documents